1Mioli VA,Balestra E,Bibiano L,et al.Epidemiology of viral hepatitis in dialysis centers:A national survey.Nephron,1992,6i:278-83
2Oguchi H,Miyasaka M,Tokunaga S,et al.Hepatitis virus infection (HBV and HCV) in.eleven Japanese hemodialysis units.Clin Nephrol,1992,38:36-43
3Tokars JI,Miller ER,Alter MJ,et al.National surveillance of dialysis in the United States.Semin Dial,2000,13:75-85
4Burdick RA,Bragg-CreshamJL,Woods JD,et al.Pattern of hepatitis B prevalence and seroconversion in hemodialysig units from three continents:The DOPPS.Kidney Int,2003,63:2222-9
5Jankovic N,Cala S,Nadinic B,et al.Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff:A two year follow-up.Int J Artif Organs,1994,17:137-40
6Otedo AE,McLigeyo SO,Okoth FA,et al.Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.S Afr Med J,2003,93:380-4
7Teles SA,Martins RMB,Vanderboght B,et al.Hepatitis B virus:Geno-types and subtypes in Brazilian hemodialysis patients.Artif Organs,1999,23:1074-8
8Covic A,Iancu L,Apetrei C,et al.Hepatitis virus infection in hameodialysis patients from Moldavia.Nephrol Dial Transplant,1999,14:40-5
9Souza KP,Luz JA,Teles SA,et al.Hipatitis B and C in the hemodialysis unit of Tocantins,Brazil:Serological and molecular profiles.Mem Inst Oswaldo Cruz,2003,98:599-603
10Girndt M,Sester M,Sester U,et al.Detective expression of B7-2(CD86) on moncytes of dialysis patients correlates to the uremia-associated immune defect.Kidney Int,2001,59:1382
9Burdick RA, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The doops. Kidney Int, 2003, 63: 2222- 2229.
10Yakaryilmaz F,Gurbuz OA,Guliter S, et al. Prevalence of occult hepatitis B and hepatitis C virus infections in turkish hemodialysis patients. Ren Fail, 2006,28:729-735.
